|
Investigation of this event is pending and a supplemental report will be sent upon its completion.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
It was reported that a patient with a ventricular assist device experienced multi organ system failure and failure to thrive, which resulted in death.The event was not related to the device or the implant procedure according to the treating physician's medical opinion.No device malfunction, procedural issue, infection, or allegation against the device was reported.No testing or imaging results were provided.
|
|
A supplemental report is being submitted for investigation completion.Product event summary: (b)(6) was not returned for evaluation.This complaint is associated with a clinical adverse event.A review of the manufacturing documentation was not performed as the reported event is not related to a manufacturing or servicing issue.Based on the available information, including the occurrence of the event several years post-implant and the statement by the physician that the event is unrelated to the device, the device most likely did not cause or contribute to the reported event.Of note, information provided by the site indicated that the patient experienced multi-organ system failure and failure to thrive, and subsequently expired.Per the instructions for use, multi-organ failure and death are known potential complications associated with the implantation of a vad.There was no evidence that the patient had a history of similar adverse events.Possible clinical factors that may have contributed to this event include the patient¿s pre-existing history and related comorbidities, the progression of their underlying disease, issues related to the therapeutic use of anticoagulant and antiplatelet medications and the patient's complex post-operative course.There are possible patient, pharmacological and procedural factors that may have contributed to this event.Investigation of this event is completed and the file will be closed.If new information is received, the file will be re-opened and a supplemental will be submitted.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|